Knowthestock.com
BCRX - Biocryst Pharmaceuticals Inc.

Sell

Weak GrowthEarnings/Profit is Negative
WeakStrong
WeakStrong

36%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 41.67%
Operating Income turning Positive
Net Income is Negative but improving
Earnings Per Share (EPS) is Negative but improving
Net Margin is -10.62%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.93
Debt Ratio is 1.94
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.66
Cash Flow is WEAK
Cash from Operations is Negative but improving
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Biocryst Pharmaceuticals Inc. (BCRX) - https://www.biocryst.com/
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
Exchange - NASDAQ
Industry - Biological Product (except Diagnostic) Manufacturing
Sector - Manufacturing
CEO - Jon Stonehouse
Employees - 496
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.